About
Novel drugs for obesity and anti-aging cosmedicine products
Areas of Focus
Categories
Small Molecule PharmaceuticalTaiwan
Team (2)
Scientific Team
Scientific TeamScientific Team
Caliway Biopharmaceuticals
team_member
經營團隊
MANAGEMENT TEAM經營團隊The Callaway management team comprises experts in the biopharmaceutical industry with decades of experience in drug discovery, drug development, and commercialization.
Caliway Biopharmaceuticals
team_member
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
840
By Phase
PHASE3: 1PHASE2: 10PHASE1: 1
By Status
COMPLETED: 10NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07140939Lead Sponsor
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
PHASE3Not yet recruiting
300 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2026
NCT06303570Lead Sponsor
A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas
PHASE2Recruiting
20 participants
Started: Nov 27, 2024 · Completed: Apr 30, 2026
NCT06005441Lead Sponsor
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
PHASE2Completed
173 participants
Started: Nov 10, 2023 · Completed: Oct 18, 2024
NCT05736107Lead Sponsor
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
PHASE2Completed
107 participants
Started: May 30, 2023 · Completed: May 20, 2024
NCT05836779Lead Sponsor
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
PHASE2Completed
23 participants
Started: May 10, 2023 · Completed: Jan 5, 2024
Locations (1)
Headquarters
New Taipei City, Taiwan
Map
Loading map...